(Last updated: September 2021)

Appendix B: Panel Roster and Financial Disclosures

Invasive Mycoses

Invasive Mycoses (Cryptococcosis, Histoplasmosis, Coccidioidomycosis)
Member Institution Financial Disclosure
Company Relationship
Neil Ampel University of Arizona, College of Medicine None N/A
David Boulware University of Minnesota Medical School

Appili Therapeutics

Matinas BioPharma

Research Support (paid to institution)
Richard Hamill Baylor College of Medicine None N/A
Carol Kauffman* University of Michigan Medical School and Veterans Affairs Ann Arbor Healthcare System

Cidara

Laboratoires SMB S.A.

Data Safety Monitoring Board
Marisa Miceli University of Michigan Medical School

SCYNAXIS

F2G

Mayne

Research Support (paid to institution)
SCYNEXIS Data Safety Monitoring Board
Astellas Consulting
Peter Pappas The University of Alabama at Birmingham, School of Medicine

Astellas Pharma

Merck

Research Support (paid to institution)
Cidara Therapeutics Scientific Advisory Board
SCYNEXIS Advisory Board (Research Support)
John Perfect Duke University, School of Medicine Pfizer Scientific Advisory Board
* Group lead

Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting is from July 2021 through July 2022.

 

Download Guidelines